Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 65, Issue 12
Volume 65, Issue 12
15 December 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 65, Issue 12, 15 December 2017

NEWS

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages i–ii, https://doi.org/10.1093/cid/cix891

IN THE LITERATURE

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix890

IDSA GUIDELINE

Andi L Shane and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 1963–1973, https://doi.org/10.1093/cid/cix959

INVITED COMMENTARY

Ferric C Fang and Robin Patel
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 1974–1976, https://doi.org/10.1093/cid/cix730

ARTICLES AND COMMENTARIES

Tami H Skoff and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 1977–1983, https://doi.org/10.1093/cid/cix724

Tdap vaccine administered to a mother during the third trimester of pregnancy is 77.7% effective at preventing pertussis in infants <2 months of age.

Jonathan L Golob and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 1984–1991, https://doi.org/10.1093/cid/cix699

Low alpha diversity in stool microbiota at neutrophil recovery associates with increased severe graft-versus-host disease (GVHD), greater abundance of oral Actinobacteria or Firmicutes, and decreased abundance of intestinal Lachnospiraceae in stool microbiota at neutrophil recovery associated with increased severe GVHD.

José Molina and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 1992–1999, https://doi.org/10.1093/cid/cix692

This stewardship program based on a bundle of noncompulsory measures, including structured educational interviews as a main innovation, has effectively reduced the incidence of MDR bacteria and associated mortality rates through sustained reduction in antibiotic pressure over a 5-year period.

Bradley J Gardiner and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2000–2007, https://doi.org/10.1093/cid/cix696

In a retrospective cohort study of 170 heart, liver, and kidney transplant recipients, secondary prophylaxis with valganciclovir following treatment of cytomegalovirus disease was not shown to have any sustained benefit on the likelihood of relapse.

Mark S Riddle and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2008–2017, https://doi.org/10.1093/cid/cix693

The findings demonstrate the efficacy and safety of 3 single-dose loperamide-adjuncted antibiotic therapies. Comparable effectiveness of single-dose rifaximin was shown. Colonization with extended-spectrum β-lactamase–producing Escherichia coli was reported, but at a lesser rate compared with other observational studies.

Michael R Jordan and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2018–2025, https://doi.org/10.1093/cid/cix698

Surveys of human immunodeficiency virus drug resistance in children aged <18 months in 5 African countries show high levels of nonnucleoside reverse transcriptase inhibitor resistance. Results support use of non-nonnucleoside reverse transcriptase inhibitors in first-line antiretroviral therapy in this population.

Martin Walker and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2026–2034, https://doi.org/10.1093/cid/cix616

We use a mathematical model fit to clinical trial data to estimate the efficacy of multiple-dose ivermectin regimens against onchocerciasis. We found marked macrofilaricidal activity of regimens used in routine mass drug administration, calling for revised projections on elimination timeframes.

Carlos A Gomez and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2035–2041, https://doi.org/10.1093/cid/cix728

Targeted panfungal sequencing was highly sensitive (96.6%) and specific (98.2%) in known cases of invasive fungal disease. The diagnostic yield (62.9%) in suspected cases was dependent on the amount of input tissue. Fungal sequencing had an impact on patient management.

Kristine M Erlandson and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2042–2049, https://doi.org/10.1093/cid/cix645

Although statins and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers demonstrated modest negative neurocognitive effects on single cognitive domains, these effects were overwhelmed by lack of effect on the primary outcome of global neurocognitive function and by the well-established cardiovascular benefits.

Erin M Kelly and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2050–2056, https://doi.org/10.1093/cid/cix716

Heavy alcohol use accelerates liver fibrosis progression in people with HIV/hepatitis C virus (HCV); the impact of light use is not clear. In this prospective longitudinal study, we found no evidence that light alcohol use influences liver fibrosis progression in HIV/HCV-coinfected women.

Vincent Lo Re
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2057–2059, https://doi.org/10.1093/cid/cix720
Leonardo Martinez and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2060–2068, https://doi.org/10.1093/cid/cix632

There have been no studies to investigate whether glycemic control is related to tuberculosis infection. In a population-based study with more than 4000 participants and 700 diabetics, several biomarkers for glycemic control modified the relationship between tuberculosis infection and diabetes.

Michelle S Toleman and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2069–2077, https://doi.org/10.1093/cid/cix539

This study identifies a community cluster of methicillin-resistant Staphylococcus aureus transmission missed by routine practice and provides genomic evidence for transmission of a typically nosocomial lineage within community rather than hospital settings. Systematic whole-genome sequencing may increase detection of such outbreaks.

Dimitrios Paraskevis and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2078–2084, https://doi.org/10.1093/cid/cix717

For 94.3% of migrant injectors, the origin of their HIV-1 infection was assumed to be in Greece (postmigration). For injectors infected in Greece, transmissions for subtype A and CRF14_BG occurred more frequently among migrants than would be expected by chance.

Camila González-Beiras and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2085–2090, https://doi.org/10.1093/cid/cix723

Haemophilus ducreyi is the cause of a high proportion of cutaneous ulcers in the tropical yaws-endemic areas. Cutaneous ulcers caused by H. ducreyi heal at 14 days after treatment with single-dose oral azithromycin.

Andreas Vestergaard Jensen and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2091–2098, https://doi.org/10.1093/cid/cix703

We assessed the prevalence of prediabetes, undiagnosed diabetes, and risk factors associated with undiagnosed diabetes among patients with community-acquired pneumonia. Undiagnosed diabetes and prediabetes were prevalent. Long-term mortality among patients with undiagnosed diabetes was high compared to patients without diabetes.

Lauren Platt and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2099–2104, https://doi.org/10.1093/cid/cix691

Bordetella pertussis infection is thought to result in 4–20 years of immunity against subsequent symptomatic pertussis infection. We report 27 cases of recurrent pertussis in children in which the second infection occurred 0–4 years after the first.

Esther Arguello Perez and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2105–2111, https://doi.org/10.1093/cid/cix725

Healthcare workers (HCWs) historically have low acceptance and completion rates for treatment of latent tuberculosis infection. This retrospective study of HCWs demonstrates that shorter treatment regimens (rifampin or rifapentine/isoniazid) result in higher completion rates than with a traditional isoniazid regimen.

Federico Pulido and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2112–2118, https://doi.org/10.1093/cid/cix734

The results of the DUAL trial support that a dual-therapy regimen of boosted darunavir and lamivudine for maintenance of virological suppression is as efficacious and as tolerable as triple therapy with boosted darunavir and 2 nucleos(t)ide reverse transcriptase inhibitors.

BRIEF REPORTS

Norman L Beatty and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2119–2121, https://doi.org/10.1093/cid/cix697
Gregory Heath and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2122–2125, https://doi.org/10.1093/cid/cix683
Tafese Beyene and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2126–2129, https://doi.org/10.1093/cid/cix613

REVIEW ARTICLE

Anne M Lachiewicz and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2130–2136, https://doi.org/10.1093/cid/cix682

Patients with burn injuries are at high risk for infections with multidrug-resistant organisms. The risk of infection with multidrug-resistant organisms increases with burn center length of stay. A multidisciplinary approach that includes an infectious diseases specialist is recommended.

VIEWPOINTS

Richard R Watkins and Stan Deresinski
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2137–2143, https://doi.org/10.1093/cid/cix675

Sepsis represents a major threat to human health worldwide. The multiple decision points in optimizing empiric antibiotic therapy in sepsis indicate a need for intense surveillance by antimicrobial stewardship programs in optimizing patient outcomes.

INVITED ARTICLE

HEALTHCARE EPIDEMIOLOGY

Mitchell J Schwaber and Yehuda Carmeli
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2144–2149, https://doi.org/10.1093/cid/cix615

A public health crisis in Israel caused by carbapenem-resistant Enterobacteriaceae exposed major gaps in infection control. In response, Israel established a national infection control infrastructure. The steps taken in building this infrastructure and benefits realized from its creation are described.

Valeria Fabre and Sara E Cosgrove
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2150–2152, https://doi.org/10.1093/cid/cix619

PHOTO QUIZ

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Page 2153, https://doi.org/10.1093/cid/cix589

ANSWER TO THE PHOTO QUIZ

Tim C Neefs and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2154–2155, https://doi.org/10.1093/cid/cix595

CORRESPONDENCE

Jaan Peter Naktin
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2156–2157, https://doi.org/10.1093/cid/cix544
John A Branda and Allen C Steere
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2157–2158, https://doi.org/10.1093/cid/cix545
Michel Drancourt
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Page 2158, https://doi.org/10.1093/cid/cix712
David P Moore and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Page 2159, https://doi.org/10.1093/cid/cix715
Ilaria Baccani and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages 2159–2160, https://doi.org/10.1093/cid/cix729

ERRATUM

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Page 2161, https://doi.org/10.1093/cid/cix759

ELECTRONIC ARTICLES

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages e38–e44, https://doi.org/10.1093/cid/cix859
Andi L Shane and others
Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Pages e45–e80, https://doi.org/10.1093/cid/cix669

COVER

Clinical Infectious Diseases, Volume 65, Issue 12, 15 December 2017, Page NP, https://doi.org/10.1093/cid/cix958
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close